Interleukin-1β in coronary arteries of patients with ischemic heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 1000-1006

  Galea, Joseph ^a   Armstrong, Johanna ^a   Gadsdon, Patricia ^a   Holden, Hazel ^a   Francis, Sheila E ^a   Holt, Cathy M ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

atherosclerosis; coronary artery; interleukin 1

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; ADVENTITIA; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISCHEMIC HEART DISEASE; MACROPHAGE; MALE; PRIORITY JOURNAL;

EID: 0029793624     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.1000     Document Type: Article

References (47)

1. Dinarello CA. Biology of interleukin 1. FASEB J. 1988;2:108-115.
2. di Giovine FS, Duff GW. Interleukin 1: the first interleukin. Immunol Today. 1990;11:13-20.
3. Duff GW. Peptide regulatory factors in non-malignant disease. Lancet. 1989;1:1432-1435.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
5. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet. 1991;338:732-736.
6. Dinarello CA. Modalities for reducing interleukin-1 activity in disease. Trends Pharmacol Sci. 1993;14:155-159.
7. Libby P, Wyler DJ, Janicka MW, Dinarello CA. Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis. 1985;5:186-191.
8. Libby P, Warner SJ, Friedman GB. Interleukin-1, a mitogen for human vascular smooth muscle that induces the release of growth factors and inhibitory prostanoids. J Clin Invest. 1988;81:487-498.
9. Libby P, Miao P, Ordovas JM, Schaefer EJ. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol. 1985;124:1-8.
10. Bonin PD, Fici GJ, Singh JP. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte-derived factor. Exp Cell Res. 1989;181:475-482.
11. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA. Interleukin-1 acts on cultured human vascular endothelium to increase adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest. 1985;76:2003-2011.
12. Schliemer RP, Rutledge BK. Cultured human endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin-1, endotoxin and tumour-promoting phorbol diesters. J Immunol. 1986;136:649-654.
13. Cavender DE, Haskard DO, Joseph B, Ziff M. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol. 1986;136:203-207.
14. Rasmussen L, Seljelid R. The modulatory effects of lipoprotein on the release of interleukin-1 by human peritoneal macrophages stimulated by WF-1, 3-D polyglucose derivatives. Scand J Immunol. 1989;29:477-484.
15. Haga Y, Takata K, Araki N, Sakamoto K, Akagi M, Morino Y, Horiuchi S. Intracellular accumulation of cholesteryl esters suppresses production of lipopolysaccharide-induced interleukin 1 by rat peritoneal macrophages. Biochem Biophys Res Commun. 1989;160: 874-880.
16. Beutler BA, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol. 1985;6:3969-3971.
17. Montesano R, Mossaz A, Ryser J-E, Orci L, Vassali P. Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol. 1984;99:1706-1715.
18. Martin S, Murata K, Bukart V, Gillis S, Kolb H. Interleukin-1 and IFN-gamma increase vascular permeability. Immunology. 1988;64: 301-305.
19. Mckenna TM, Reusch DW, Simpkins CO. Macrophage-conditioned medium and interleukin 1 suppress vascular contractility. Circ Shock. 1988;25:187-196.
20. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986;83:4533-4537.
21. Stern DM, Bank I, Nawroth PP, Cassimeris J, Kisiel W, Fenton JW, Dinarello C, Chess L, Jaffe EA. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med. 1985; 162: 1223-1235.
22. Wang A, Doyle M, Mark D. Quantitation of mRNA using the polymerase chain reaction. Proc Natl Acad Sci USA. 1989;86: 9717-9721.
23. Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol. 1993;142:1721-1728.
24. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol. 1991; 138:951-960.
25. Ross R, Masuda J, Raines EW, Gown AW, Katsuda S, Sasahara M, Maiden LT, Masuko H, Sato H, Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 1990; 248:1009-1012.
26. Gottlob R. The preservation of venous endothelium by dissection without touching by an atraumatic technique of vascular anastomosis. Minerva Chir. 1977;32:693-700.
27. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r×c contingency tables. J Am Stat Assoc. 1983;78:427-434.
28. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 1992;116:1292-1300.
29. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396.
30. Gay CG, Winkles JA. Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1991;88:296-300.
31. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest. 1986;78:1432-1438.
32. Warner SJC, Auger KR, Libby P. Human interleukin-1 induces gene expression in human vascular smooth muscle cells. J Exp Med. 1981; 165:1316-1331.
33. Lee E, Grodzinsky AJ, Libby P, Clinton SK, Lark MW, Lee RT. Monocytes induce metalloproteinase secretion by cultured human vascular smooth muscle cells through interleukin 1. Circulation. 1995;92(suppl):425. Abstract.
34. Warner SJC, Auger KR, Libby P. Interleukin 1 induces interleukin 1, II: recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol. 1987; 139:1911-1917.
35. Cozzolino F, Torcia M, Aldinucci D, Ziehe M, Almerigogna F, Bani D, Stein DM. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A. 1990;87:6487-6491.
36. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumour necrosis factor and immune interferon. J Immunol. 1986;137:1893-1896.
37. Cybulski MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
38. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med. 1986;163:1595-1600.
39. Dejana E, Breviario F, Erroi A, Bussolino F, Mussoni L, Gramse M, Pintucci G, Casoli B, Dinarello CA, VanDamme T. Modulation of endothelial cell function by different molecular species of interleukin 1. Blood. 1987;69:695-699.
40. Beasley D, Cohen RA, Levinsky NG. Interleukin 1 inhibits contraction of vascular smooth muscle. J Clin Invest. 1989;83:331-335.
41. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature. 1990;344:254-257.
42. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage-colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 1992;140:301-316.
43. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimai microvessels in coronary atherosclerosis. Am J Pathol. 1993;143:164-172.
44. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimai hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992; 89:465-473.
45. Thomas KA, Rios-Candelore MR, Gallego GG, Di Salvo J, Bennett C, Rodkey J, Fitzpatrick S. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci U S A. 1985;82:6409-6313.
46. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA. 1985;82:6507-6511.
47. Hughes S, Crossman D, Hall PA. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res. 1993;27:1214-1219.